Your browser doesn't support javascript.
loading
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.
Kråkenes, Torbjørn; Herdlevaer, Ida; Raspotnig, Margrethe; Haugen, Mette; Schubert, Manja; Vedeler, Christian A.
Affiliation
  • Kråkenes T; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Herdlevaer I; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Raspotnig M; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Haugen M; Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Schubert M; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Vedeler CA; Department of Neurology, Haukeland University Hospital, Bergen, Norway.
Ann Neurol ; 86(2): 316-321, 2019 08.
Article in En | MEDLINE | ID: mdl-31148214
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Autoantigens / Cerebellum / Paraneoplastic Cerebellar Degeneration / Nerve Tissue Proteins Limits: Animals / Female / Humans / Male Language: En Journal: Ann Neurol Year: 2019 Type: Article Affiliation country: Norway
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Autoantigens / Cerebellum / Paraneoplastic Cerebellar Degeneration / Nerve Tissue Proteins Limits: Animals / Female / Humans / Male Language: En Journal: Ann Neurol Year: 2019 Type: Article Affiliation country: Norway